SCM
PHGE icon

Silverarc Capital Management’s BiomX PHGE Stock Holding History

Silverarc Capital Management’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-75
Closed -$78 – 98
2021
Q2 		$78 Buy
75
+3
+4% +$3.49K 0.03% 94
2021
Q1 		$98K Hold
72
– – 0.05% 89
2020
Q4 		$88K Buy
+72
New +$83.4K 0.05% 81

Other funds holding PHGE

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return

Silverarc Capital Management's PHGE Position: Q3 2021 in Review

Silverarc Capital Management sold out of BiomX (PHGE) in Q3 2021, closing a stake of 75 shares — an estimated $78 sold.

Silverarc Capital Management first reported a position in PHGE in Q4 2020 and held it in 3 quarters. The position peaked at $98K in Q1 2021. 17 funds tracked by Wall St. Rank hold PHGE as of Q3 2021.

  • Silverarc Capital Management reported no remaining BiomX position as of Q3 2021 after selling out during the quarter.
  • Silverarc Capital Management sold 75 BiomX shares in Q3 2021, an estimated $78.
  • Silverarc Capital Management first reported a position in BiomX in Q4 2020 and held it in 3 quarters.
  • Silverarc Capital Management's BiomX position peaked at $98K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held BiomX as of Q3 2021.

Based on Silverarc Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.